In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection

被引:72
作者
Blaak, H
Brouwer, M
Ran, LJ
de Wolf, F
Schuitemaker, H
机构
[1] Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Dept Clin Viroimmunol, NL-1066 CX Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Expt & Clin Immunol Lab, Amsterdam, Netherlands
关键词
D O I
10.1086/514219
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In 7 long-term survivors (LTS) and 8 progressors, all carrying solely non-syncytium-inducing variants, a possible correlation between in vitro virus replicative capacity, virus load, and clinical course of human immunodeficiency virus type 1 (HIV-1) infection was analyzed, Late in infection, 3 LTS and 7 progressors had a high virus load, which coincided with the presence of rapid-replicating viruses, In contrast to progressors, LTS maintained relatively high and stable CD4 T cell counts, Four LTS persistently had relatively slow-replicating viruses and a low virus load, even after 6.6-9 years of seropositive follow-up. All virus isolates from 1 of these LTS had a 4-aa deletion in nef, These results suggest a correlation between the in vitro replicative capacity of non-syncytium-inducing HIV-1 variants and virus load, The presence of HIV-I variants with relatively low replicative capacity throughout infection may have contributed to the beneficial clinical course in half of the LTS in this study.
引用
收藏
页码:600 / 610
页数:11
相关论文
共 60 条
[1]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[2]  
ASJO B, 1986, LANCET, V2, P660
[3]   Temporal relationship between human immunodeficiency virus type 1 RNA levels in serum and cellular infectious load in peripheral blood [J].
Blaak, H ;
deWolf, F ;
vantWout, AB ;
Pakker, NG ;
Bakker, M ;
Goudsmit, J ;
Schuitemaker, H .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05) :1383-1387
[4]   RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[5]   A CROSS-SECTIONAL COMPARISON OF PERSONS WITH SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING HUMAN-IMMUNODEFICIENCY-VIRUS [J].
BOZZETTE, SA ;
MCCUTCHAN, JA ;
SPECTOR, SA ;
WRIGHT, B ;
RICHMAN, DD .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) :1374-1379
[6]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208
[7]   BIOLOGIC FEATURES OF HIV-1 THAT CORRELATE WITH VIRULENCE IN THE HOST [J].
CHENGMAYER, C ;
SETO, D ;
TATENO, M ;
LEVY, JA .
SCIENCE, 1988, 240 (4848) :80-82
[8]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[9]   OPTIMAL INFECTIVITY IN-VITRO OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REQUIRES AN INTACT NEF GENE [J].
CHOWERS, MY ;
SPINA, CA ;
KWOH, TJ ;
FITCH, NJS ;
RICHMAN, DD ;
GUATELLI, JC .
JOURNAL OF VIROLOGY, 1994, 68 (05) :2906-2914
[10]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED REPLICATIVE CAPACITY DEVELOP DURING THE ASYMPTOMATIC STAGE BEFORE DISEASE PROGRESSION [J].
CONNOR, RI ;
HO, DD .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4400-4408